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In the last decade tuberculosis (TB) has reemerged as a major worldwide public health
hazard with increasing incidence among adults and children. Although cases among
children represent a small percentage of all TB cases, infected children are a reservoir
from which many adult cases will arise. TB diagnosis in children usually follows discovery
of a case in an adult, and relies on tuberculin skin testing, chest radiograph, and clinical
signs and symptoms. However, clinical symptoms are nonspecific, skin testing and chest
radiographs can be difficult to interpret, and routine laboratory tests are not helpful.
Although more rapid and sensitive laboratory testing, which takes into account recent
advances in molecular biology, immunology, and chromatography, is being developed,
the results for children have been disappointing. Better techniques would especially
benefit children and infants in whom early diagnosis is imperative for preventing
progressive TB.
Despite the availability of effective preventive
measures and chemotherapy, the prevalence of
tuberculosis (TB) is increasing in the developing
world and in much of the industrialized world as
well (1-4). According to World Health Organiza-
tion (WHO) estimates, in 1990 there were 8 mil-
lion new cases of TB and 3 million deaths due to
the disease worldwide; 1.3 million new cases and
450,000 deaths were among children under 15
years of age (5). WHO projects that 90 million new
cases and 30 million deaths–including 4.5 million
deaths among children–will occur in the 1990s
(6,7). In developing countries, the risk for TB
infection and disease is relatively uniform in the
population; annual rates of infection often exceed
2% (5,6). In industrialized countries, risk is more
uneven and depends on the individual’s past or
present activities and exposure to persons at high
risk for the disease (Table 1). From 1987 to 1991,
the number of TB cases among children under 5
years of age in the United States increased by
49% from 674 cases to 1006 (8). Although cases
among children represent a small percentage of
all TB cases, infected children are a reservoir
from which many adult cases will arise. The risk
for infection by Mycobacterium tuberculosis
among children depends primarily on the level of
risk of developing infectious TB for the adults in
their immediate environment, especially their
household. Because most current diagnostic tests
for TB infection and disease have low specificity
and therefore low positive predictive values,
epidemiologic investigation continues to be im-
portant in establishing the diagnosis of TB in
children. In industrialized countries, clinicians
and public health professionals in TB services
must always ask: Has the child been exposed to
an adult with infectious pulmonary TB? 
Natural History of TB in Children
The natural history of TB in children follows a
continuum; however, it is useful to consider three
basic stages: exposure, infection, and disease (1).
Exposure implies that the child has had recent
and substantial contact with an adult or adoles-
cent who has suspected or confirmed contagious
pulmonary TB (a source case). Exposed children
are usually identified during followup investiga-
tions for persons with suspected pulmonary TB
by public health workers (9); the child’s tuberculin
skin test (TST) is nonreactive, the results of the
chest radiograph are normal, and the child is free
of physical signs or symptoms of TB. Some
exposed children are infected with M. tubercu-
losis. The clinician cannot know immedi-
ately which exposed children are infected because
the development of delayed-type hypersensitivity
to tuberculin may take up to 3 months. Unfortu-
nately, in children under 5 years of age, severe
TB—especially meningeal and disseminated
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the TST becomes reactive (10). Young children in
the exposure stage should receive chemotherapy,
usually isoniazid, until infection can been ex-
cluded.
TB infection is first signaled by a reactive
Mantoux TST. In this stage, there are no signs or
symptoms, and the results of the chest radio-
graph are either normal or show only fibrotic
lesions or calcifications in the lung parenchyma
or regional lymph nodes. In developing countries,
TB infection is rarely discovered and almost
never treated. In most industrialized countries,
children with a positive TST receive isoniazid for
6 to 12 months.
TB disease occurs when signs and symptoms
or radiographic manifestations caused by M. tu-
berculosis appear. Radiographic abnormalities
and clinical manifestations in infected children
probably are influenced by the host inflammatory
reaction more than by the number of organisms.
Studies show that in 40% to 50% of infants with
untreated TB infection disease develops within 1
to 2 years (11). The risk decreases to 15% among
older children. In 25% to 35% of children TB is
extrapulmonary and more difficult to confirm
bacteriologically.
In adults, the distinction between TB infection
and disease is usually clear because most disease
is caused by reactivation of dormant organisms
years after infection. Disease in adults is usually
accompanied by symptoms, and patients fre-
quently are infectious. In children, who most
often have primary disease, the interval between
infection and disease can be several months to
several years, and radiographic abnormalities
often are not accompanied by symptoms; more-
over, these children are rarely infectious. The
major reason for separating infection from dis-
ease in children is that the perception affects the
approach to treatment: infection is generally
treated with a single anti-TB drug, whereas ac-
tive disease is treated with two or more drugs.
The rationale for the difference in treatment is
that the likelihood of emergence of resistance to
a drug increases as the bacillary population in-
creases (3). This distinction is somewhat artificial
in children since infection and primary disease
are parts of a continuum. Because anti-TB medi-
cations are well tolerated by children and are
relatively inexpensive in industrialized
countries, the usual paradigm of infection and
disease encourages overtreatment rather than
undertreatment. Asymptomatic lymphade-
nopathy and mild lung parenchymal changes are
labeled and treated as disease.
When evaluating new diagnostic tests the ba-
sic differences between the pathophysiology of TB
in adults and children should be considered.
Among children with recent TB infection, active
multiplication of mycobacteria occurs with or
without the presence of radiographic abnormali-
ties or clinical symptoms. For example, gastric
aspirate cultures yield M. tuberculosis from a
small proportion of recently infected children
with normal chest radiographs. One can antici-
pate that most diagnostic tests designed to detect
M. tuberculosis in adults with TB disease will be
positive in some proportion of children who have
what is usually called TB infection. It will take
careful consideration and investigation to
determine if and how the results of these new
tests should influence the definitions and treat-
ment of TB infection and disease in children.
Table 1. Persons at high risk for Mycobacterium tuberculosis
infection in industrialized countries                                                      
Persons likely to be exposed to or become infected with
M. tuberculosis
· Close contacts of a person with infectious tu-
berculosis (TB)
· Foreign-born persons from high-incidence ar-
eas (e.g., Asia, Africa, Latin America)
· The elderly
· Residents of long-term care facilities (e.g.,
correctional facilities and nursing homes)
· Persons who inject drugs
· Other groups identified locally as having in-
creased prevalence of TB (e.g., migrant 
farm workers or homeless persons)
· Persons who may have occupational expo-
sure to TB
Persons at high risk of developing TB disease once
infected
· Persons recently infected with M. tuberculo-
sis (within the past 2 years)
· HIV-infected persons
· Persons with immunosuppressing condi-
tions or medication use
· Persons with a history of inadequately
treated TB 
· Infants
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Tuberculin Skin Test (TST)
The Mantoux TST, which uses five tuberculin
units of purified protein derivative, is the stand-
ard method for detecting infection by M. tubercu-
losis. The reaction is measured as millimeters of
induration after 48 to 72 hours. Since TST is the
only way to determine asymptomatic infection by
M. tuberculosis, the false-negative rate cannot be
calculated. A negative TST does not rule out TB
disease in a child. Approximately 10% of other-
wise normal children with culture-proven TB do
not react to tuberculin initially (12,13). Most of
these children have reactive skin tests during
treatment, which suggests that TB disease con-
tributed to the immunosuppression. In most
cases, the anergy occurs to all antigens, but in
some cases, reactions to tuberculin are negative
but reactions to other antigens remain positive
(13). The rate of false-negative TST is higher in
those who are tested soon after becoming infected
with severe TB; in children with debilitating or
immunosuppressive illnesses, malnutrition, or
viral and certain bacterial infections; in infants;
and if poor technique is used (1,14). The rate of
false-negative TST in children with TB who are
infected with human immunodeficiency virus
(HIV) is unknown, but it is certainly higher than
10%.
False-positive reactions to TST are often at-
tributed to asymptomatic infection by environ-
mental nontuberculous mycobacteria (NTM).
Vaccination with M. bovis can cause transient
reactivity to a subsequent TST, but the associa-
tion is weaker than commonly recognized. Most–
80% to 90% in several studies–children who
received BCG as infants have a nonreactive TST
at 5 years of age (15-17). Among older children or
adolescents who receive BCG, most develop a
reactive skin test initially; however, by 10 to 15
years postvaccination, 80% to 90% have lost tu-
berculin reactivity (18,19). Skin test reactivity
can be boosted, probably by antigenic stimula-
tion, by serial testing in many children and adults
who received BCG (20). Various factors determine
the TST reaction size after receipt of BCG (1).
Many recipients of BCG have a reactive TST
because they are infected with M. tuberculosis
and are at risk for disease, especially if they have
had recent contact with an infectious TB patient
(18). In general, TST reaction should be
interpreted in the same manner for persons who
have received BCG (20) and for unvaccinated
persons.
The relatively low sensitivity and specificity of
TST make the test very useful for persons at high
risk for TB infection or disease but undesirable
for use in persons at low risk (21,22). The predic-
tive values of TST can be improved by varying the
size of induration considered positive according to
epidemiologic risk factors for infection (Table 2).
However, most of even 15-mm reactions in chil-
dren at low risk are false-positive results, and
testing of persons at low risk should be discour-
aged. Although the scheme in Table 2 is scientifi-
cally and mathematically valid, it assumes that
the clinician and family are willing and able to
develop an accurate history for TB risk factors for
children and adults in their environments.
Clinical Signs and Symptoms
Two scenarios lead the clinician to suspect that
a child has TB disease. The first occurs when TB
is considered during the differential diagnosis for
an ill child. This is a common scenario in the
developing world but is less common in developed
countries. Infants are more likely to be sympto-
matic than older children with pulmonary TB.
The most common symptoms are cough, fever,
wheezing, and failure to gain weight (13). Clinical
Table 2. Cut-off size of reactive area for a positive Mantoux
tuberculin reaction                                                                                
  ³ 5 mm   ³10 mm  ³ 15 mm         
Persons who had Foreign-born persons No  risk  factors
 contact  with  from  high-prevalence
 infectious  persons  countries
Persons with an Residents of prisons, 
 abnormal  chest   nursing  homes,
 radiograph  institutions
HIV-infected and Persons who inject drugs
 other  immuno-
 suppressed  persons
Persons with other 
 medical  risk  factors
Health-care workers
Locally identified 
  populations at high risk
Children in contact with 
 adults  at  high  risk
Infants 
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wheezes over the affected lung field are most
common. Signs and symptoms of extrapulmonary
TB are referable to the involved organ. The sen-
sitivity and specificity of signs and symptoms are
extremely low and can lead to both overdiagnosis
and underdiagnosis when radiographs and other
tests are not available.
The second scenario occurs when evaluating a
child who has had significant contact with an
adult with suspected or confirmed TB. Usually
the TST is applied first and is reactive. A sub-
sequent chest radiograph or physical examina-
tion leads to discovery of early disease. The child
is usually relatively asymptomatic. In the United
States, about 50% of childhood TB cases are dis-
covered in this manner (13). 
Radiologic Studies
Evidence of pulmonary TB in chest radio-
graphs varies (23,24), but usually radiographs
show enlargement of hilar, mediastinal, or sub-
carinal lymph nodes and lung parenchymal
changes (Figure 1). Most of the radiographic ab-
normalities are caused by a combination of lung
disease and the mechanical changes induced by
partial or complete airway obstruction resulting
from enlarging intrathoracic nodes. The most
common findings are segmental hyperinflation
then atelectasis, alveolar consolidation, intersti-
tial densities, pleural effusion, and, rarely, a focal
mass. Cavitation is rare in young children but is
more common in adolescents, who may develop
reactivation disease similar to that seen in adults.
The development of radiographic techniques,
such as computed tomography (CT) scanning,
illustrates some of the issues that arise when
newer and more sensitive diagnostic tests become
available (24). A CT scan may show enlarged or
prominent mediastinal or hilar lymph nodes in
some children with recent TB infection and a
normal chest radiograph (25). In the absence of a
CT scan, the child’s disease stage would be called
TB infection, and single drug therapy would be
used. Many studies, involving thousands of chil-
dren have shown this treatment to be successful.
However, when the CT scan shows mild ade-
nopathy, the clinician may consider this finding
indicative of TB disease and treat with several
drugs, although this probably is not necessary in
the absence of drug resistance. These findings
reinforce the idea that pediatric TB is a
continuum, and the distinction between
infectionand disease is somewhat artificial. There
is no current role for the CT scan in the evaluation
of the asymptomatic TB-infected child with a
normal chest radiograph. This scan can be helpful
in selected cases to demonstrate endobronchial
disease, pericardial invasion, early cavitation,
and bronchiectasis resulting from pulmonary TB
when the chest radiograph is abnormal but the
pathologic process is not clear.
Mycobacterial Detection and Isolation
Despite recent advances, early mycobacteri-
ologic diagnosis of TB still relies primarily on
examination of acid-fast-stained smears from
clinical specimens. It is the easiest, least expen-
sive, and most rapid procedure for obtaining pre-
liminary information. However, children under
12 years of age with pulmonary TB rarely produce
sputum and are usually unable to expectorate
voluntarily. When sputum samples cannot be ob-
tained, gastric aspirate samples are used for
detection and isolation of M. tuberculosis. Even
though an acid-fast bacilli (AFB) stain of sputum
is positive in up to 75% of adults with pulmonary
TB, fewer than 20% of children with TB have a
positive AFB smear of sputum or gastric aspirate
(26,27). The newer fluorochrome stains, such as
auramine and rhodamine, are superior to classic
carbolfuchsin stains (28). The rates of positive
AFB stain from body fluids and tissues in children
with extrapulmonary TB also are low, and false-
positive results caused by NTM disease are com-
mon, especially in cervical lymph nodes.
Figure 1. Chest radiograph of a girl with pulmonary
tuberculosis. Note the significant hilar adenopathy in
association with atelectasis, the so-called
collapse-consolidation lesion.
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confirmation is not needed. Diagnosis is made on
the basis of a positive TST, clinical and radio-
graphic findings suggestive of TB, and history of
contact with an adult source case. The drug-sus-
ceptibility test results from the source case isolate
can be used to design the optimal treatment for
the child. However, cultures should be obtained
from the child if the source patient is unknown or
has a drug-resistant organism and if the child is
immunocompromised or has extrapulmonary TB.
The best specimen for culture from children
with suspected pulmonary TB is the early morn-
ing gastric aspirate obtained in the hospital by
using a nasogastric tube before the child arises
and peristalsis empties the stomach of the respi-
ratory secretions swallowed overnight (29,30).
Three consecutive morning gastric aspirates yield
M. tuberculosis in only 30% to 50% of cases, al-
though the yield from infants is as high as 70%
(14). The culture yield from other body fluids or
tissues from children with extrapulmonary TB is
usually less than 50% (13). Gastric aspiration is
inconvenient, expensive, and uncomfortable. The
culture yield from random, outpatient gastric as-
pirates has not been determined recently. There-
fore, this procedure cannot be recommended but
should be studied.
Bronchoscopy
The role of bronchoscopy in evaluating children
for TB is controversial. The culture yield is lower
from bronchoscopy specimens than from properly
obtained gastric aspirates (29,31). Most children
do not need flexible fiberoptic bronchoscopy, but
the procedure may be useful in diagnosing endo-
bronchial TB and excluding other causes of
pulmonary abnormality, particularly in immuno-
compromised children, such as those with HIV
infection in whom other opportunistic infections
may coexist with or mimic TB. In a recent study
of 36 children with pulmonary TB, bronchoscopy
showed endobronchial involvement in 42%; most
(63%) of these children had no clinical or radio-
graphic evidence of endobronchial TB (31). This
technique may be used to determine if a child
might benefit from corticosteroid therapy, but
guidelines for making this decision have not been
established.
Clinical Scoring System
TB is an enormous problem in developing coun-
tries, where about 95% of cases occur (6). Cost,
technical difficulties, and lack of resources make
TB diagnosis in children very difficult in these
countries. Various clinical scoring systems have
been proposed on the basis of available informa-
tion and tests (32,33) (Table 3). Although helpful,
many of these systems have low sensitivity and
specificity. However, even in industrialized
countries, the triad of a positive tuberculin skin
test, an abnormal radiograph, and a history of
exposure to an adult with TB remains the most
effective method for diagnosing TB in children.
New Diagnostic Techniques
Polymerase Chain Reaction (PCR)
Diagnostic PCR is a technique of DNA ampli-
fication that uses specific DNA sequences as
markers for microorganisms (34). In theory, this
technique can detect a single organism in a speci-
men such as sputum, gastric aspirate, pleural
fluid, cerebrospinal fluid, or blood. Recent publi-
cations show that various PCR techniques, most
using the mycobacterial insertion element IS6110
as the DNA marker for M. tuberculosis-complex
organisms, have a sensitivity and specificity
greater than 90% for detecting pulmonary TB in
adults (35,36). However, these tests are not per-
formed correctly in all clinical laboratories (36)
Table 3. A set of criteria for the diagnosis of pulmonary
tuberculosis (TB) in children when culture is not available             
A. Positive acid-fast stain of sputum or gastric aspirate
or
B. Two or more of the following:
· History of contact with a tuberculous adult
· Cough lasting longer than 2 weeks
· A reactive tuberculin skin test
³ 10 mm in children without prior BCG 
vaccination
³ 15 mm in children with prior BCG 
vaccination
· Radiographic findings compatible with TB 
· Response to anti-TB therapy (increased
body weight by 10% after 2 months,
decrease in symptoms)
                                                                                 
Source: ref. 33.
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microscopic examination of sputum (34). The cost
involved and the need for sophisticated equip-
ment and scrupulous technique to avoid cross-
contamination of specimens preclude the use of
PCR techniques in many developing countries.
PCR may have a special role in the diagnosis of
extrapulmonary TB and pulmonary TB in chil-
dren since sputum smears are usually unreveal-
ing in these cases.
Use of PCR for detecting M. tuberculosis in
children has not been evaluated extensively.
Pierre et al. (37) used an IS6110-based PCR to
detect M. tuberculosis in gastric aspirate samples
from 22 children with pulmonary TB. They found
that 15 (25%) of 59 samples were positive; how-
ever, testing multiple samples or testing samples
at least twice improved the sensitivity. When
three samples from the same patient were tested
two times each, two or more positive results were
obtained from 9 of 15 children with TB, but from
0 of 17 controls. However, 2 of 65 single samples
from controls were positive by PCR. Using an
IS6110-based PCR assay, Starke et al. (38) tested
gastric aspirates from 35 hospitalized children
with pulmonary TB and 30 controls to detect M.
tuberculosis. When compared with the clinical
diagnosis, PCR had a sensitivity of 40% and speci-
ficity of 80%. Six controls had false-positive PCR
results; one had a recent TB infection, two had
NTM disease, and three had conditions unrelated
to mycobacterial infection. Delacourt et al. (39)
studied 199 specimens from 68 children with sus-
pected TB. An IS6110-based PCR identified M.
tuberculosis in clinical samples from 83% of chil-
dren with disease compared to the low yield from
positive AFB smears (21%) and positive cultures
(42%) (39). PCR identified 70% of children with
clinical pulmonary TB but no other microbiologic
proof of the infection. However, 39% of children
with infection but no radiographic or clinical dis-
ease also had positive PCR results. These results
again demonstrate the arbitrariness of the
distinction between TB infection and disease in
children.
It appears that PCR may have a useful but
limited place in evaluating children for TB. A
negative PCR result never eliminates TB as a
diagnostic possibility, and a positive result does
not confirm it. PCR’s major use will be in evalu-
ating children with significant pulmonary dis-
ease, when the diagnosis is not easily established
by clinical or epidemiologic grounds. PCR may be
particularly helpful in evaluating immunocom-
promised children with pulmonary disease, al-
though published reports of PCR performance in
such children are lacking. PCR may also aid in
establishing the diagnosis of extrapulmonary TB,
though only rare case reports have been publish-
ed. However, performing PCR on gastric aspirates
is not a useful test to distinguish between TB
infection and disease and should not be used for
children with normal chest radiographs.
Serology and Antigen Detection
Despite dozens of studies published over the
past several decades, serology has found little
place in the routine diagnosis of TB in adults or
children. Several recent studies have used the
enzyme-linked immunosorbent assay (ELISA) to
detect antibodies to various purified or complex
antigens of M. tuberculosis in children. Rosen (40)
used mycobacterial sonicates in an ELISA on
samples from 31 children with clinical TB and
found a sensitivity of 26% and a specificity of 40%.
This ELISA was influenced by recent BCG vacci-
nation in children under 5 years of age. Barrera
et al. (41) used an ELISA that detects antibodies
to purified protein derivative and found a sensi-
tivity of 51% for culture-positive pulmonary TB
cases in children, but the sensitivity was only 28%
for the clinical cases. Hussey et al. (42) used an
autoclaved suspension of M. tuberculosis to detect
antibodies in serum from 132 children with clini-
cal pulmonary TB; the test was 62% sensitive and
98% specific. Higher sensitivity was obtained
among patients with positive culture results
(69%, n = 35), miliary TB (100%, n = 6), tuberculous
meningitis (80%, n =  15), and pleural effusion
(78%, n = 16). No correlation was observed with
the tuberculin skin-test result, BCG vaccination,
or nutritional status whereas duration of therapy,
increasing age and chronicity of infection were
positively correlated. Delacourt et al. (43) used an
ELISA to detect IgG and IgM antibodies directed
against mycobacterial antigen A60 in children
with TB. At a chosen specificity of 98%, IgG was
detected in 68% of children with clinical disease
when results were highly controlled for age and
prior BCG vaccination. IgM detection had only a
19% sensitivity. However, using the same anti-
A60 ELISA at a defined specificity of 95%,
Turneer et al. (44) found the IgG sensitivity to be
26% for past TB, 6% for asymptomatic primary
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adenitis. No available serodiagnostic test for TB
has adequate sensitivity, specificity, or reproduci-
bility under various clinical conditions to be use-
ful for diagnosing TB in children.
Mycobacterial antigen detection has been
evaluated in clinical samples from adults, but
rarely from children (45,46). Two recent assays
detecting M. tuberculosis-specific antigens
yielded high sensitivity and specificity in various
clinical specimens from adults with TB (47,48).
Measurement of tuberculostearic acid, a myco-
bacterial mycolic acid, has been used to detect M.
tuberculosis in clinical specimens (49). Brooks et
al. (50) demonstrated a sensitivity of 95% and
specificity of 91% when chromatographic profile
of carboxylic acids and detection of tubercu-
lostearic acid were combined and compared with
culture results and clinical findings in adults with
pulmonary TB; however, these techniques require
technically advanced equipment and expertise,
which are not available where TB in children is
most common. Their sensitivity and specificity in
children are unknown.
Implications for HIV Infection and Drug Resistance
The resurgence of TB over the last decade has
coincided with the HIV pandemic. HIV-infected
infants and children are in close contact with
their caregivers, who may be infected with HIV
and M. tuberculosis and are at high risk of devel-
oping infectious TB as they become immunocom-
promised. None of the available diagnostic tests
for TB infection or disease in children has been
evaluated systematically in children with HIV
infection and pulmonary disease or suspected TB.
In adults with HIV infection and TB, the sensitiv-
ity of diagnostic tests that rely on the host im-
mune response, such as the TST or serology, is
much lower than in nonimmunocompromised TB
patients. It is likely that the tests’ sensitivity also
will be lower in HIV-infected children with TB.
Tests that directly detect M. tuberculosis, such as
PCR or antigen detection assays, may be particu-
larly important for HIV-infected children. The
culture yield of M. tuberculosis from children with
HIV infection and TB is unknown but appears to
be similar to that from non-HIV-infected children.
The most important diagnostic clue for detecting
TB in HIV-infected children is a history of contact
with an adult who has infectious TB. Since TB
may not have yet been diagnosed in this adult, a
rapid and aggressive evaluation for TB in adults
who care for the child is a critical part of the
evaluation of the child.
The current prevalence of drug resistance
among M. tuberculosis isolates in the United
States is 8% to 14% (51, 52). Drug resistance is
most common in patients who received treat-
ment, are not responding to therapy, do not ad-
here to treatment, live in developing countries,
are immunocompromised, are prisoners, are
homeless, or are children exposed to adults at
increased risk for drug resistance. Drug-resistant
TB has increased significantly among children
(52). Because of low culture yields from children
with TB, the clinician must often rely on the
antimicrobial susceptibility results for the M. tu-
berculosis isolate obtained from the adult source
case who presumably infected the child. This
again emphasizes the crucial need to identify and
evaluate the source case for every child with TB.
The rapid identification of drug-resistant organ-
isms is necessary for control of drug-resistant TB.
Various new methods, such as high-performance
liquid chromatography or PCR and DNA se-
quence analysis, may help to identify and test for
antimicrobial susceptibility within a few days of
diagnosis, but these techniques remain experi-
mental.
Summary
Most recently developed sensitive and specific
diagnostic tests have not found a place in the
routine evaluation of children with suspected TB.
Clinical criteria, particularly skin-test results,
radiographic changes, and documented exposure
to an infectious adult remain standard diagnostic
methods. In industrialized countries, the local
public health entity is a crucial partner to the
clinician in establishing the diagnosis in the child
and determining if drug resistance is present. As
new diagnostic tests are developed, they must be
evaluated against clinical criteria. The basic dif-
ferences in pathophysiology of TB in adults and
children must be considered before new tests are
applied in pediatrics. It will be crucial to study the
new techniques in children and not simply ex-
trapolate from results for adults with TB.
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